U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Combination Products
  3. Jurisdictional Information
  4. RFD Jurisdictional Decisions
  5. Capsular Decisions - Products Assigned to CDRH
  1. RFD Jurisdictional Decisions

Capsular Decisions - Products Assigned to CDRH

A. Devices

  • Agent used to prepare skin for adhesion of bandages
  • Gel used as barrier to prevent surgical adhesions
  • Hyaluronic acid viscosupplement for treatment of arthritis pain
  • Absorbable barrier to prevent surgical adhesions
  • Polysaccharide intended to act as protective barrier
  • Radiation-containing glass beads for cancer treatment
  • Device to hyperpolarize gas for use during magnetic resonance imaging
  • Extracorporeal lipid removal system
  • Physical barrier for dental use
  • Oral wound dressing providing physical barrier
  • Device to provide controlled hypoxia
  • Needle-free injector for administration of a biological product
  • Needle-free injector for administration of a drug
  • Processed animal connective tissue for use in orthopedic surgery
  • LAL-based in vitro test to aid in the diagnosis of fungal infections
  • Device for disinfection of harvested bone
  • Collagen/oxidized regenerated cellulose wound dressing
  • Intraperitoneal drug delivery system
  • Device that controls delivery of medication from implanted delivery system
  • Human allograft demineralized bone matrix with additives to make putty or paste
  • Animal collagen bone void filler
  • Medical maggots for wound treatment
  • Solution for rinsing preserved organs prior to reimplantation
  • Device to produce sterile water for injection
  • Laser-activated surgical tissue welding tube
  • Vitreous visualization agent
  • Ozone production/delivery device for dental use
  • Device that produces oxygenated water for topical oxygen therapy
  • Device for pulsatile delivery of therapeutic solutions
  • Kit for intestinal permeability testing
  • Peak flow meter accessory for metered dose inhalers
  • Bone and collagen allograft for bone grafting
  • Device to monitor use of metered dose inhalers
  • In vitro diagnostic test for hepatitis (for patient management)
  • Immunodiagnostic assay for hepatitis (for individual patient use)
  • Branched DNA technology-based quantification assay for Hepatitis C (for patient management)
  • Branched DNA technology-based quantification assay for Hepatitis B (for patient management)
  • Injectable polymer for urological use
  • Sterile water for inhalation therapy
  • Sterile water with saline for inhalation therapy
  • Dressing that binds enzymes from wounds
  • Adjunct to a PAP machine to treat breathing disorder
  • Wound cleansing/debriding product
  • Device that provides humidified hyperbaric oxygen for wound management
  • Device for mixing and delivery of fibrin sealants
  • Dual syringe applicator for delivery of fibrin sealants
  • Reusable autoinjector for use with specified prefilled syringe cartridges
  • Animal tissue-derived scaffold for ligament replacement
  • Surfactant-based lubricant to act as adhesion barrier in pelvic and abdominal surgery
  • Heating/drug delivery device for cancer treatment
  • Device and inhaled gas mixture to measure cardiopulmonary function
  • Topical paste for wound covering
  • Accessories to blood/fluid warming device
  • Polymeric sealant to seal air leaks in the lung
  • Computer-based system to help monitor and manage Parkinson’s Disease
  • More than minimally manipulated structural human tissue for use in vascular procedures
  • Device with tracer for evaluation of lung function

B. Combination Products with Device Primary Mode of Action

  • Breath collection/analysis devices and drug for H. pylori diagnosis
  • Laser and photosensitizing agent for antimicrobial use
  • Dialysate with drug component
  • Heparin-coated cardiovascular stent
  • Drug-eluting cardiovascular stent
  • Radiolabeled drug-eluting cardiovascular stent
  • Vascular graft with antibiotic
  • Dental floss with fluoride
  • Dental floss with antimicrobial agent
  • Dental filling material with antimicrobial agent
  • Dental sealant with antimicrobial agent
  • Dental cement with antimicrobial agent
  • Periodontal barrier with antibiotic
  • Adhesive bandage with antibiotic
  • Physical/chemical embolization product
  • Cardiovascular stent and injectable drug
  • Orthopedic prosthesis coated with growth factor
  • Coronary stent coated with biological product
  • Dental prophylaxis paste with fluoride and antimicrobial agent
  • Dental implant coated with autologous cells
  • Dental implant and synthetic peptide used to promote its integration
  • Wound dressing impregnated with drug ointment
  • Occlusive wound dressing with biologic component
  • Catheter lock flush solution with antimicrobial and anticoagulant agents
  • Dental wax with anesthetic for discomfort associated with orthodontic procedures
  • Dental restorative material with fluoride
  • Breath collection/analysis devices and drug for diagnosis of lactose maldigestion
  • Breath collection/analysis devices and drug for diagnosis of gastric emptying disorders
  • Breath collection/analysis devices and drug to monitor enzyme activity
  • Breath test kit and drug for use during pharmacological research
  • Breath collection/analysis devices and drug for diagnosis of intestinal bacterial overgrowth
  • Breath test and drug for assessment of small intestinal function
  • Blood test and drug for detection of H. pylori in the stomach
  • Embolization device coated with a radiopharmaceutical drug
  • Root canal cleanser with antimicrobial agent
  • Device with enzyme mimic for orthopedic use
  • Bone void filler with antibiotic
  • Menstrual tampon with drug to neutralize pH within the tampon
  • Fluorescent imaging system for use during cardiac surgery
  • Tubing with drug to reduce discomfort during placement
  • Device and lithium chloride indicator dilution to monitor cardiac output
  • Device for delivery and filtration of chemotherapeutic agents to organs
  • Device and filtration system to administer chemotherapy to limbs
  • Polymer-astringent granules for wound/laceration management
  • Laser and photosensitizing agent for dental use
  • Non-occlusive wound dressing with drug
  • Wound dressing with analgesic
  • Wound dressing with antimicrobial agent
  • Bone void filler with blood component to act as matrix and enhance handling properties
  • Vascular graft with drug-eluting mesh to maintain graft patency
  • Breath test kit and drug to measure liver function
  • Scaffold/matrix for wound treatment
  • Device and soluble intravenous gases to evaluate pulmonary function
  • Chemiluminescent light and dye for oral lesion marking
  • Collagen-thrombin hemostatic agent
  • Gelatin granules-thrombin hemostatic agent
  • Breath test kit and drug for diagnosis of insulin resistance
  • Cryotherapy device and salicylic acid for wart removal
  • Central venous catheter with antimicrobial coating
  • Therapeutic ultrasound device and gas microspheres for thrombolytic therapy
  • Surgical mesh with anesthetic coating
  • Scented respiratory device
Back to Top